BSE filing, NSE: JKCEMENT. Summary written from the filing by ALFA Finder's alert engine.
JK Cement Ltd: key numbers
- Share price
- ₹4,785.50
- Market cap
- ₹36,977 Cr
- Revenue (annual)
- ₹13,722 Cr
- Net profit (annual)
- ₹992.5 Cr
- P/E (TTM)
- 38.6×Sector 32.2×
- Promoter holding
- 45.66%+0.00% QoQ
- FII holding
- 18.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JK Cement Ltd
All →JK Cement Earnings Call Transcript: Key Takeaways
Q2 FY27 standalone revenue ₹3,595 Cr (+26% YoY), EBITDA ₹500 Cr (+14%), margin 14.2% (down 1.7ppt YoY). PAT ₹190 Cr (+8%). Grey volume up 21%.
JK Cement Board Meeting Outcome
JK Cement's board approved appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for 60 months. The appointment takes effect from 30 September 2027.
- Execution
- 60 months, effective from 2027-09-30
JK Cement Capacity Expansion: ₹130 Cr Investment
JK Cement's board approved a 75,000 KLPA capacity addition at subsidiary JK Maxx Paints, costing Rs 130 Crore. Completion is expected within 12 months of construction start.
- Value
- ₹130.0 Cr
- Execution
- 12 months (from the start of construction)
- paints manufacturing capacity
- 75000.0 KLPA
JK Cement Other Announcement
J. K. Cement's board appointed Price Waterhouse Chartered Accountants LLP as statutory auditor for a 60-month term from 30 September 2027. No monetary value is disclosed.
JK Cement Debt & Borrowing
JK Cement filed an auditor's certificate on secured NCD security cover and covenant compliance as at September 30, 2026. It confirms asset book values and covenant compliance.
JK Cement Investor Presentation: Key Takeaways
Q2 FY27 standalone revenue ₹3,595cr (+26% YoY), EBITDA ₹500cr (+14%), margin 14.2%, PAT ₹190cr (+8%). Grey volume +21%; 50 MTPA by FY30 target.
Other board meeting date announcements
All →Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.
CHD Chemicals Board Meeting Date
CHD Chemicals intimated a board meeting on 04 Nov 2026 to consider unaudited half-yearly results for September 2026. Trading window remains closed until 06 Nov 2026.
Max Estates Board Meeting Date
Max Estates Limited has informed exchanges that its board will meet on 4 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 6 November 2026.
GKP Printing & Packaging Board Meeting Date
G.K.P. Printing & Packaging announced a board meeting on 4 November 2026 to approve unaudited results for the quarter ended 30 September 2026. Trading window has been closed for insiders since 1 October 2026.
ADF Foods Board Meeting Date
ADF Foods will hold a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The meeting will also consider an interim dividend for FY2026-27.
MKP Mobility Board Meeting Date
MKP Mobility will hold a board meeting on November 6, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results.